Équipements Laboratoire en Gros : Fournisseurs Vérifiés

Laboratory equipment for wholesale procurement includes: centrifuges — benchtop microcentrifuges (1.5–2ml tubes, up to 21,000 × g), clinical centrifuges (blood tube processing, 15–50ml tubes), refrigerated high-speed centrifuges (preparative work, cell harvesting), and ultracentrifuges (>100,000 × g for particle separation); PCR thermocyclers and real-time PCR systems — conventional (end-point) PCR thermocyclers; real-time qPCR systems (Applied Biosystems QuantStudio, Bio-Rad CFX, Roche LightCycler, Bio-gene, Analytik Jena from Europe; Tianlong, Sansure, Liferiver from China — the COVID-19 pandemic dramatically expanded Chinese RT-PCR manufacturer capacity and export certification); ELISA microplate readers — absorbance readers (most common), fluorescence readers, luminescence readers; wavelength range and kinetics capability are key specifications; biosafety cabinets (BSCs) — Class I (personnel protection only, negative pressure), Class II Type A2 (most common for clinical/research labs — personnel and environment protection from non-volatile materials), Class II Type B2 (full exhaust for toxic volatile compounds), Class III (maximum containment for BSL-3/4 work); NSF/ANSI 49 (USA) and EN 12469 (EU) govern BSC performance; incubators — CO₂ incubators for cell culture (5% CO₂, 37°C, humidity control — HEPA-filtered jacketed models from Thermo Forma, Sanyo/Panasonic, Binder; Chinese brands BioFreeze, Bluepard), dry incubators (microbiology, 25–70°C), BOD incubators for environmental monitoring; microscopes — bright-field compound (clinical pathology, haematology), phase contrast (cell culture), fluorescence (immunofluorescence, FISH), and inverted (cell culture observation); Zeiss, Leica, Olympus, Nikon premium tier; Motic, Meiji, Labomed competitive mid-tier; and analytical balances — 0.001–0.1g readability; calibrated traceability certificates required for GMP laboratory use.

Laboratory equipment used for in-vitro diagnostic purposes is regulated under EU IVDR 2017/746 (In Vitro Diagnostic Regulation) in Europe — which replaced the IVDD 98/79/EC and became fully applicable from May 2022 with transition provisions to 2025–2027 for legacy-certified IVD devices. IVDR classifies IVD devices into Classes A, B, C, D (increasing risk): Class A (low risk — general laboratory equipment, specimen collection containers not claiming diagnostic performance) — self-declared CE; Class B (moderate-low risk — general IVD devices for self-testing and professional use); Class C (moderate-high risk — devices detecting infections, HLA typing, oncology markers); Class D (high risk — devices for blood group/tissue typing, NAT for blood-borne pathogens, HIV diagnostics). For laboratory analysers used to generate diagnostic results: the test kit/reagent system is typically Class C or D requiring Notified Body certification; the instrument platform (analyser) is CE-marked but often in a different class than the reagent. For wholesale procurement of clinical laboratory instruments: ISO 13485 certification is expected of manufacturers; ISO/IEC 17025 accreditation is required for the testing laboratory itself (not the instrument manufacturer) — it governs technical competence for testing and calibration; CLIA (Clinical Laboratory Improvement Amendments) certification is required for US clinical laboratories — instrument procurement must be compatible with CLIA waived, moderate, or high complexity categories. For calibration traceability: clinical analysers used for quantitative measurements require calibrators with traceability to SI units via national metrology institutes (NIST in USA, PTB in Germany); request calibration uncertainty documentation.